je.st
news
Sinovac Biotech Ltd. (SVA) Upgraded by Zacks Investment Research to "Hold"
2015-12-09 05:49:51| Biotech - Topix.net
According to Zacks, "Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, SARS, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.
Tags: to
research
hold
investment
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||